top of page
Search


Stem Cells May Improve Dialysis Access for Kidney Disease Patients
Published on Mayo Clinic News Network Mayo Clinic researchers report that fat-derived mesenchymal stem cells can help prevent vein...
Oct 1, 2025


New Gene Therapy Slows Huntington’s Disease by 75%
Published on Sky News A breakthrough gene therapy called AMT-130 has slowed progression of Huntington’s disease by as much as 75% in a...
Oct 1, 2025


Lab-Grown Kidney Assembloids Show Real Function
Published on Drug Target Review USC Stem Cell scientists have created kidney assembloids that function like real organs, combining...
Sep 24, 2025


A-Gene Case Study: QbD Principles in Gene Therapy CMC
Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Gene initiative demonstrates how Quality by...
Sep 24, 2025


A-Cell Case Study: QbD Principles in Cell Therapy CMC
Published on Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s A-Cell initiative showcases how Quality by...
Sep 24, 2025


FDA Approves TREMFYA® for Ulcerative Colitis Induction
Published via FDA & EU regulatory updates The FDA has approved TREMFYA® as the first and only IL-23 inhibitor with both subcutaneous and...
Sep 24, 2025


Mitochondria Linked to Emerging Roles in Adult Pluripotent Stem Cells
Published in Frontiers in Bioengineering and Biotechnology A new review highlights mitochondria as central regulators of pluripotency,...
Sep 23, 2025


Pfizer to Acquire Metsera in $4.9B Deal Expanding Obesity Pipeline
Published on LinkedIn (via Spencer Knight) Pfizer announced plans to acquire Metsera for up to $4.9B, adding GLP-1 and amylin-based...
Sep 23, 2025


Roche to Acquire 89bio in $3.5B Deal Expanding Liver Disease Portfolio
Published on LinkedIn (via Spencer Knight) Roche announced a $3.5B acquisition of 89bio, adding pegozafermin, a late-stage therapy for...
Sep 19, 2025


LB Pharmaceuticals Raises $285M in Landmark Biotech IPO
Published on LinkedIn (via Spencer Knight) LB Pharmaceuticals completed the largest biotech IPO of 2025 to date, raising $285M to advance...
Sep 13, 2025


Regenerative Therapies Proposed for ED and Peyronie’s Disease
Published in International Journal of Impotence Research A new commentary outlines how low-intensity shockwave therapy and platelet-rich...
Sep 13, 2025


Novartis Acquires Tourmaline Bio in $1.4B Deal to Strengthen Cardiovascular Portfolio
Published on LinkedIn (via Spencer Knight) Novartis has announced its $1.4 billion acquisition of Tourmaline Bio, a New York–based...
Sep 11, 2025


Umbilical Cord–Derived MSC Therapy Shows Multi-Year Benefits in Retinitis Pigmentosa
Published in Stem Cells Translational Medicine (Oxford Academic) A large open-access study reports long-term safety and functional gains...
Sep 11, 2025


CRISPR-Based Triple-Modality Imaging Revolutionizes Stem Cell Tracking in Stroke
Published in Radiology (RSNA) A new editorial highlights the promise of CRISPR-based triple-modality imaging for tracking stem cell...
Sep 8, 2025


Cell and Gene Therapy Market Poised for Blockbuster Growth
Published by Alliance for Regenerative Medicine The cell and gene therapy sector is rapidly expanding, with two blockbuster products...
Sep 7, 2025


Aberrant Neural Stem Cell Activity Linked to Autism Development
Published on Molecular Psychiatry A new study has identified a critical link between autism and the abnormal behavior of quiescent neural...
Sep 6, 2025


Placental Stem Cells Enable New Research Into Pregnancy Complications
Published on Technology Networks (original story from Kyoto University) Japanese researchers have successfully developed human placental...
Sep 6, 2025


Scientists Identify Protein Behind Aging, Opening Door to Anti-Aging Therapies
Published on Futura-Sciences South Korean researchers have identified a specific chemical form of the HMGB1 protein that appears to...
Sep 4, 2025


New Approach for Smarter, Safer Cancer Treatment
Published on University of California San Francisco (UCSF) Researchers at UCSF have developed a groundbreaking personalized chemotherapy...
Sep 4, 2025


ACCESS Study Expands Stem Cell Transplant Options for Diverse Patients
Published on: Targeted Oncology The NMDP-sponsored ACCESS study is improving outcomes for mismatched stem cell transplants, particularly...
Sep 3, 2025
bottom of page
